|30.19||-0.4200||-1.37%||Vol 101.63K||1Y Perf -21.97%|
|Oct 3rd, 2023 15:25 DELAYED|
|-0.09 -0.29%||- -|
|Target Price||48.50||Analyst Rating||Moderate Buy 1.67|
|Potential %||59.70||Finscreener Ranking||★★★★+ 57.08|
|Insiders Trans % 3/6/12 mo.||-/-/-100||Value Ranking||★★★★+ 58.75|
|Insiders Value % 3/6/12 mo.||-/-/-100||Growth Ranking||★★★★+ 63.94|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-100||Income Ranking||— -|
|Price Range Ratio 52W %||23.49||Earnings Rating||Sell|
|Market Cap||1.43B||Earnings Date||2nd Nov 2023|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||2nd Nov 2023|
|Estimated EPS Next Report||0.27|
|EPS Growth Next 5 Years %||11.50|
|Avg. Weekly Volume||131.71K|
|Avg. Monthly Volume||236.48K|
|Avg. Quarterly Volume||169.81K|
Apollo Medical Holdings Inc. (NASDAQ: AMEH) stock closed at 30.61 per share at the end of the most recent trading day (a -0.78% change compared to the prior day closing price) with a volume of 155.25K shares and market capitalization of 1.43B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 555 people. Apollo Medical Holdings Inc. CEO is Kenneth Sim / Thomas S. Lam.
The one-year performance of Apollo Medical Holdings Inc. stock is -21.97%, while year-to-date (YTD) performance is 3.45%. AMEH stock has a five-year performance of 60.68%. Its 52-week range is between 26.89 and 40.94, which gives AMEH stock a 52-week price range ratio of 23.49%
Apollo Medical Holdings Inc. currently has a PE ratio of 20.00, a price-to-book (PB) ratio of 2.53, a price-to-sale (PS) ratio of 1.62, a price to cashflow ratio of 23.00, a PEG ratio of 1.74, a ROA of 7.78%, a ROC of 10.03% and a ROE of 14.87%. The company’s profit margin is 5.92%, its EBITDA margin is 7.50%, and its revenue ttm is $845.15 Million , which makes it $18.56 revenue per share.
Of the last four earnings reports from Apollo Medical Holdings Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.27 for the next earnings report. Apollo Medical Holdings Inc.’s next earnings report date is 02nd Nov 2023.
The consensus rating of Wall Street analysts for Apollo Medical Holdings Inc. is Moderate Buy (1.67), with a target price of $48.5, which is +59.70% compared to the current price. The earnings rating for Apollo Medical Holdings Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Apollo Medical Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Apollo Medical Holdings Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.61, ATR14 : 1.25, CCI20 : -75.88, Chaikin Money Flow : -0.10, MACD : -1.29, Money Flow Index : 46.12, ROC : -3.32, RSI : 38.21, STOCH (14,3) : 31.41, STOCH RSI : 0.74, UO : 47.42, Williams %R : -68.59), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Apollo Medical Holdings Inc. in the last 12-months were: Albert Young (Sold 0 shares of value $-579 168 ), Kenneth Sim (Sold 0 shares of value $-1 048 907 ), Thomas S. Lam (Option Excercise at a value of $1 048 865)
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
This could take some time, please wait.